An experimental treatment made from a plant virus is effective at protecting against a broad range of metastatic cancers in mice, shows a new study from the University of California San Diego.
Radiopharmaceutical biotech Radionetics in fundraising mode with $54.2M so far
Radionetics Oncology is in the midst of a fundraising drive worth $68.7 million, with the California-based company having raised $54.2 million so far, per an
August 17, 2023